Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy

Chinese Medical Journal (Taipei)

Volumn 63, Issue 10, 2000, Pages 729-736

  Chiou, T J ^a   Tzeng, W F ^a   Wang, W S ^a   Yen, C C ^a   Fan, F S ^a   Liu, J H ^a   Chen, P M ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adverse event; Chemotherapy induced emesis; Complete response; Dexamethasone; Granisetron; Ondansetron

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; GRANISETRON; ONDANSETRON;

ADOLESCENT; ADULT; AGED; ANTIEMETIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; VERTIGO; VOMITING;

ADOLESCENT; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HUMANS; MALE; MIDDLE AGED; NAUSEA; ONDANSETRON; SEROTONIN ANTAGONISTS; VOMITING;

EID: 0033764109     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The current role of antiemetic drugs in oncology: A recent revolution in patients symptoms control
2. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: A randomized controlled trial
3. Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis
4. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy
5. 3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration
6. Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis
7. Methodology in antiemetic trials
8. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study
9. Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis
10. Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy
11. Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy. A dose-ranging study
12. An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant
13. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy
14. Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: A double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone
15. Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy
16. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: A multicenter, double-blind, randomized parallel study
17. Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis
18. Comparison of the efficacy and side effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy. A prospective randomized study
19. Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting